Ignite Creation Date:
2025-12-24 @ 11:40 PM
Ignite Modification Date:
2026-01-02 @ 5:15 AM
Study NCT ID:
NCT00203151
Status:
TERMINATED
Last Update Posted:
2011-04-12
First Post:
2005-09-13
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Study to Evaluate the Tolerability, Safety and Effectiveness of Edratide in the Treatment of Lupus
Sponsor:
Teva Branded Pharmaceutical Products R&D, Inc.
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
TV-4710/201
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
None
Responsible Party Affiliation:
Old Name:
Rivka Kreitman, Ph.D., Vice President, Innovative Research & Development
Old Organization:
Teva Neuroscience